CARTER CHARLES ROSS enters OVID THERAPEUTICS INC. with 44.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/8/2026ACC: 0001779359-26-000002
Officer· Chief Financial Officer
Since Jul 2026
44.38K
Baseline shares
100% direct
44.38K
Direct ownership
1 position
406.25K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned44.38K
Total
44.38K direct44.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 44.38K | Direct |
| Total | 44.38K | 44.38K direct |
Derivative Holdings2
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
200K
Shares owned
N/A
Exercise price
1.14
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
206.25K
Shares owned
N/A
Exercise price
1.65
Expiration
—
Exercise window
—
Total
Underlying
406.25K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 1.14 | — | — | 200K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 1.65 | — | — | 206.25K | N/A |
| Total | 406.25K | 0.00 | ||||